Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT03349060

Public ClinicalTrials.gov record NCT03349060. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-04965842 MONOTHERAPY IN SUBJECTS AGED 12 YEARS AND OLDER, WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Study identification

NCT ID
NCT03349060
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
387 participants

Conditions and interventions

Interventions

  • PF-04965842 100 mg Drug
  • PF-04965842 200 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 6, 2017
Primary completion
Mar 25, 2019
Completion
Mar 25, 2019
Last update posted
Dec 9, 2019

2017 – 2019

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Clinical Research Center of Alabama, LLC Birmingham Alabama 35209
California Dermatology & Clinical Research Institute Encinitas California 92024
Rady Children's Hospital - San Diego/University of California, San Diego San Diego California 92123
TCR Medical Corporation San Diego California 92123
Clinical Science Institute Santa Monica California 90404
Florida Academic Centers Research and Education, LLC Coral Gables Florida 33134
Olympian Clinical Research Largo Florida 33770
Forward Clinical Trials, Inc. Tampa Florida 33624
Meridian Clinical Research, LLC Savannah Georgia 31406
NorthShore University HealthSystem Dermatology Clinical Trials Unit Skokie Illinois 60077
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
Dawes Fretzin Dermatology Group, LLC Indianapolis Indiana 46256
Tufts Medical Center Boston Massachusetts 02111
Henry Ford Medical Center, New Center One Detroit Michigan 48202
Somerset Skin Centre Troy Michigan 48084
MediSearch Clinical Trials Saint Joseph Missouri 64506
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Vital Prospects Clinical Research Institute, P.C. Tulsa Oklahoma 74136
Oregon Health & Science University Portland Oregon 97239
Medical University of South Carolina Investigational Drug Services Charleston South Carolina 29425
MUSC SCTR Research Nexus Clinic and Laboratory Charleston South Carolina 29425
Arlington Research Center, Inc. Arlington Texas 76011
The University of Texas Health Science Center Houston Houston Texas 77030
Texas Dermatology and Laser Specialists San Antonio Texas 78218
Virginia Clinical Research, Inc. Norfolk Virginia 23502
Pace Dermatology Associates Lakewood Washington 98499
MultiCare Allenmore Hospital Tacoma Washington 98405
MultiCare Institute for Research and Innovation Tacoma Washington 98405
Pace Dermatology Associates Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03349060, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2019 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03349060 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →